NO996270D0 - Treatment of diabetes with thiazolidinedione and <alfa> glucosidase inhibitor - Google Patents

Treatment of diabetes with thiazolidinedione and <alfa> glucosidase inhibitor

Info

Publication number: NO996270D0
Authority: NO; Norway
Prior art keywords: thiazolidinedione; alfa; diabetes; treatment; glucosidase inhibitor
Prior art date: 1997-06-18

Application number

NO996270A

Other languages

Norwegian (no)

Other versions

NO996270L (en

Inventor

Stephen Alistair Smith

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-18

Filing date

1999-12-17

Publication date

1999-12-17

1997-06-18 Priority claimed from GBGB9712865.6A external-priority patent/GB9712865D0/en

1998-03-27 Priority claimed from GBGB9806708.5A external-priority patent/GB9806708D0/en

1999-12-17 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

1999-12-17 Publication of NO996270L publication Critical patent/NO996270L/en

1999-12-17 Publication of NO996270D0 publication Critical patent/NO996270D0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Emergency Medicine (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Fodder In General (AREA)

NO996270A 1997-06-18 1999-12-17 Treatment of diabetes with thiazolidinedione and <alfa> glucosidase inhibitor NO996270D0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9712865.6A GB9712865D0 (en)	1997-06-18	1997-06-18	Novel method of treatment
GBGB9806708.5A GB9806708D0 (en)	1998-03-27	1998-03-27	Novel method
PCT/EP1998/003691 WO1998057635A1 (en)	1997-06-18	1998-06-15	Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor

Publications (2)

Publication Number	Publication Date
NO996270L NO996270L (en)	1999-12-17
NO996270D0 true NO996270D0 (en)	1999-12-17

Family

ID=26311746

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO996270A NO996270D0 (en)	1997-06-18	1999-12-17	Treatment of diabetes with thiazolidinedione and <alfa> glucosidase inhibitor

Country Status (24)

Country	Link
EP (1)	EP0975343A1 (en)
JP (1)	JP2001523271A (en)
KR (1)	KR20010013845A (en)
CN (1)	CN1274282A (en)
AP (1)	AP9901720A0 (en)
AR (2)	AR014881A1 (en)
AU (1)	AU8799998A (en)
BG (1)	BG103966A (en)
BR (1)	BR9810186A (en)
CA (1)	CA2294134A1 (en)
CO (1)	CO4940453A1 (en)
DZ (1)	DZ2519A1 (en)
EA (1)	EA200000040A1 (en)
IL (1)	IL133138A0 (en)
MA (1)	MA26510A1 (en)
NO (1)	NO996270D0 (en)
NZ (1)	NZ501345A (en)
OA (1)	OA11631A (en)
PE (1)	PE89199A1 (en)
PL (1)	PL337577A1 (en)
SK (1)	SK179499A3 (en)
TR (1)	TR199903072T2 (en)
UY (1)	UY25051A1 (en)
WO (1)	WO1998057635A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA01010820A (en)	1999-04-23	2002-06-04	Smithkline Beecham Plc	Novel pharmaceutical.
ATE442148T1 (en)	2001-04-04	2009-09-15	Ortho Mcneil Janssen Pharm	COMBINATION THERAPY USING GLUCOSE ABSORPTION INHIBITORS AND RETINOID X RECEPTOR MODULATORS
EP1381361B1 (en)	2001-04-04	2009-02-25	Ortho-McNeil-Janssen Pharmaceuticals, Inc.	Combination therapy comprising glucose reabsorption inhibitors and ppar modulators
FR2832930A1 (en) *	2001-12-03	2003-06-06	Lipha	PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND A THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF FOR THE PREPARATION OF MEDICINES FOR TREATING DIABETES
JP2004067575A (en) *	2002-08-06	2004-03-04	Yaizu Suisankagaku Industry Co Ltd	Promoter for effect of therapeutic agent for diabetes
CN101121004B (en) *	2006-08-08	2010-07-21	鲁南制药集团股份有限公司	Medicine composition containing insulin intensifier and miglitol
CN101584688B (en) *	2008-05-24	2010-11-10	鲁南制药集团股份有限公司	Medicament composition for treating diabetes and complications of diabetes
CN101584705B (en) *	2008-05-24	2010-10-27	鲁南制药集团股份有限公司	Medicament composition for treating diabetes and complications of diabetes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2101866T3 (en) *	1991-08-26	1997-07-16	Upjohn Co	LIQUID FOOD PRODUCT CONTAINING 3-GUANIDINOPROPIONIC ACID.
US5917052A (en) *	1994-09-28	1999-06-29	Shaman Pharmaceuticals, Inc.	Hypoglycemic agent from cryptolepis
TWI238064B (en) *	1995-06-20	2005-08-21	Takeda Chemical Industries Ltd	A pharmaceutical composition for prophylaxis and treatment of diabetes

1998
- 1998-06-15 EA EA200000040A patent/EA200000040A1/en unknown
- 1998-06-15 AU AU87999/98A patent/AU8799998A/en not_active Abandoned
- 1998-06-15 WO PCT/EP1998/003691 patent/WO1998057635A1/en not_active Application Discontinuation
- 1998-06-15 SK SK1794-99A patent/SK179499A3/en unknown
- 1998-06-15 EP EP98939513A patent/EP0975343A1/en not_active Withdrawn
- 1998-06-15 CN CN98806319A patent/CN1274282A/en active Pending
- 1998-06-15 AP APAP/P/1999/001720A patent/AP9901720A0/en unknown
- 1998-06-15 JP JP50375699A patent/JP2001523271A/en not_active Ceased
- 1998-06-15 BR BR9810186-2A patent/BR9810186A/en not_active IP Right Cessation
- 1998-06-15 PL PL98337577A patent/PL337577A1/en unknown
- 1998-06-15 IL IL13313898A patent/IL133138A0/en unknown
- 1998-06-15 TR TR1999/03072T patent/TR199903072T2/en unknown
- 1998-06-15 CA CA002294134A patent/CA2294134A1/en not_active Abandoned
- 1998-06-15 KR KR1019997011866A patent/KR20010013845A/en not_active Application Discontinuation
- 1998-06-17 MA MA25121A patent/MA26510A1/en unknown
- 1998-06-17 DZ DZ980129A patent/DZ2519A1/en active
- 1998-06-17 AR ARP980102885A patent/AR014881A1/en unknown
- 1998-06-17 AR ARP980102882A patent/AR013352A1/en unknown
- 1998-06-18 CO CO98034648A patent/CO4940453A1/en unknown
- 1998-06-18 PE PE1998000536A patent/PE89199A1/en not_active Application Discontinuation
- 1998-06-18 UY UY25051A patent/UY25051A1/en not_active Application Discontinuation
- 1998-07-15 NZ NZ501345A patent/NZ501345A/en unknown
1999
- 1999-12-08 BG BG103966A patent/BG103966A/en unknown
- 1999-12-17 OA OA9900295A patent/OA11631A/en unknown
- 1999-12-17 NO NO996270A patent/NO996270D0/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
PE89199A1 (en)	1999-10-23
IL133138A0 (en)	2001-03-19
BG103966A (en)	2000-07-31
BR9810186A (en)	2000-08-08
NZ501345A (en)	2001-10-26
UY25051A1 (en)	2000-09-29
EP0975343A1 (en)	2000-02-02
PL337577A1 (en)	2000-08-28
AR014881A1 (en)	2001-04-11
DZ2519A1 (en)	2003-02-01
CA2294134A1 (en)	1998-12-23
AP9901720A0 (en)	1999-12-31
CO4940453A1 (en)	2000-07-24
NO996270L (en)	1999-12-17
JP2001523271A (en)	2001-11-20
MA26510A1 (en)	2004-12-20
WO1998057635A1 (en)	1998-12-23
TR199903072T2 (en)	2000-07-21
EA200000040A1 (en)	2000-08-28
SK179499A3 (en)	2000-11-07
AU8799998A (en)	1999-01-04
KR20010013845A (en)	2001-02-26
CN1274282A (en)	2000-11-22
OA11631A (en)	2004-11-22
AR013352A1 (en)	2000-12-27

Publication	Publication Date	Title
DK0996444T3 (en)	2007-07-02	Treatment of diabetes with thiazolidinedione and metformin
DK1228067T3 (en)	2004-12-06	5-membered heterocyclic compounds with hypoglycemic and hypolipidemic activity
NO20006178L (en)	2000-12-05	Use of PEG-IFN- <alpha> and ribavirin for the treatment of chronic hepatitis C
NO984094L (en)	1999-03-09	Discharge reactor and use of the same
DK0863721T3 (en)	2000-07-17	Electronic stethoscope with idealized clock and membrane modes
NO996265D0 (en)	1999-12-17	Treatment of diabetes with rosiglitazone and insulin
FI963611A0 (en)	1996-09-13	Treatment of diabetic nephropathy with valsartan
NO996270D0 (en)	1999-12-17	Treatment of diabetes with thiazolidinedione and <alfa> glucosidase inhibitor
NO20000230D0 (en)	2000-01-17	Treatment of diabetes with thiazolidinedione, insulin secretagogue and <alfa> glucosidase inhibitor
ATE268327T1 (en)	2004-06-15	BENZAZOLE COMPOUNDS AND THEIR USE
NO996264D0 (en)	1999-12-17	Treatment of diabetes with thiazolidinedione and sulfonylurea
NO20000229D0 (en)	2000-01-17	Treatment of diabetes with thiazolidinedione and sulfonylurea
NO955258D0 (en)	1995-12-22	Medical use of enzymes
FI953674A0 (en)	1995-08-01	Heat treatment of carbonaceous material
NO20003439L (en)	2000-07-03	N-oxides of heterocyclic compounds with TNF and PDE-IV inhibitory activity
ID24355A (en)	2000-07-13	TREATMENT OF MELLITUS DIABETES WITH TIAZOLIDINADION AND ALFA-GLUCOSIDASE INHIBITORS
HUP0002669A3 (en)	2001-12-28	Treatment of diabetes with thiazolidinedione and sulphonylurea
ID20659A (en)	1999-02-11	ARCHITECTURE ABILITY OF CACHE
NO963869D0 (en)	1996-09-16	Treatment of diabetic nephropathy with valsartan
NO20014454D0 (en)	2001-09-14	Construction and application of the same
SE9603101D0 (en)	1996-08-28	Medical use of enzyme
NO930644D0 (en)	1993-02-24	ABSORBENT AND USE OF THIS

Legal Events

Date	Code	Title	Description
2003-02-24	FC2A	Withdrawal, rejection or dismissal of laid open patent application